Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;28(6):1118-1126.
doi: 10.1007/s13361-016-1542-6. Epub 2016 Dec 13.

Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains

Christopher M Crittenden  1 , Lucas D Akin  1 , Lindsay J Morrison  1 , M Stephen Trent  2 , Jennifer S Brodbelt  3
Affiliations

Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains

Christopher M Crittenden et al. J Am Soc Mass Spectrom. 2017 Jun.

Abstract

Lipid A molecules consist of a diglucosamine sugar core with a number of appended acyl chains that vary in their length and connectivity. Because of the challenging nature of characterizing these molecules and differentiating between isomeric species, an energy-resolved MS/MS strategy was undertaken to track the fragmentation trends and map genealogies of product ions originating from consecutive cleavages of acyl chains. Generalizations were developed based on the number and locations of the primary and secondary acyl chains as well as variations in preferential cleavages arising from the location of the phosphate groups. Secondary acyl chain cleavage occurs most readily for lipid A species at the 3' position, followed by primary acyl chain fragmentation at both the 3' and 3 positions. In the instances of bisphosphorylated lipid A variants, phosphate loss occurs readily in conjunction with the most favorable primary and secondary acyl chain cleavages. Graphical Abstract ᅟ.

Keywords: Acyl chain; Collisional activation; Lipid A; Tandem mass spectrometry.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Structure of lAA and the corresponding MS/MS spectra of the deprotonated lipid by: (b) CID at NCE 35, (c) HCD at NCE 25, and (d) UVPD at 2.5 mJ for seven pulses. Only the most prominent fragment ions are labeled. ERMS plots are shown in (e) HCD and (f) UVPD. The HCD ERMS plot is shown with error bars in Figure S3 to illustrate the typical standard deviations of these measurements.
Figure 2
Figure 2
Summary of sequential fragmentation of lAA upon increasing HCD energy.
Figure 3
Figure 3
lAC, lAD, and lAE structures with key cleavage sites indicated (a, b, c) and respective HCD ERMS plots (d, e, f) for the deprotonated lipids.
Figure 4
Figure 4
HCD spectra of deprotonated (a) lAD and (b) lAE. MS3 spectra in (c) to (f) reveal the sequential order of 3′α and 2′ε chain cleavage.
Figure 5
Figure 5
Structures of (a) lAF and (b) lAG. The HCD ERMS plots are shown for each doubly deprotonated lipid in (c) and (d), respectively.
Figure 6
Figure 6
lAH, lAI, and lAJ structures with key cleavage sites indicated (a, b, c) and respective HCD ERMS plots (d, e, f) for the deprotonated lipids.
See this image and copyright information in PMC

References

    1. Kaye KS, Pogue JM. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management. Pharmacother J Hum Pharmacol Drug Ther. 2015;35:949–962. - PubMed
    1. Bouchillon SK, Badal RE, Hoban DJ, Hawser SP. Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009–2011. Clin Ther. 2013;35:872–877. - PubMed
    1. Bush K. Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check. ACS Infect Dis. 2015;1:509–511. - PubMed
    1. Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI. Appraising Contemporary Strategies to Combat Multidrug Resistant Gram-Negative Bacterial Infections–Proceedings and Data From the Gram-Negative Resistance Summit. Clin Infect Dis. 2011;53:S33–S55. - PMC - PubMed
    1. Whitfield C, Trent MS. Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem. 2014;83:99–128. - PubMed